HIGHLIGHTS
- who: January and collaborators from the The University of Hong Kong, Hong Kong SAR, China have published the research: Comparative clinical-related outcomes of Chinese patent medicines for cardiac hypertrophy: A systematic review and network meta-analysis of randomized clinical trials, in the Journal: (JOURNAL)
- what: To more accurately estimate the effects of CPM, the authors explore the consistency of research evidence and the differing efficacy of all the outcome indicators between CPM which has been limited in the previous literature. In the study , a systematic review and NMA of randomized clinical trials was made . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.